clinical trial · NCT07069673
Abbott Cephea Mitral Valve Disease Registry
Abbott Medical Devices·—·recruiting·n = 1,000
Mitral RegurgitationMitral StenosisMitral Valve DiseaseMitral Valve (MV) RegurgitationMitral Annulus CalcificationMitral Valve ReplacementTranscatheter Valve Replacement
brief summary
The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.
started
Aug 13, 2025
primary completion
Dec 1, 2028
completion
Dec 1, 2028
last updated
May 12, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol